The current clinical research ecosystem—especially for chronic ambulatory conditions—is fragmented, inefficient, and unsustainable. Civia is transforming large-scale clinical studies in prevalent diseases for the future of human health by making them faster, smarter, and available in the places where people come together to work and shop. We study advanced therapies for the conditions which affect millions with obesity, cardiovascular disease, and respiratory illnesses, as well as vaccines, because that’s where we can make the greatest impact on human health. Civia sites leverage smart, AI-driven technologies to streamline operations—from scalable participant recruitment to real-time tracking of key health indicators. The vision is a world where people enjoy and value participating in research, and sponsors can obtain valid, cost-effective data efficiently as possible to advance human health.